LJAC
LABU icon

L.J. Altfest & Co’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

L.J. Altfest & Co’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,207
Closed -$1.38M – 271
2022
Q2 		$1.38M Buy
+10,207
New +$1.74M 0.25% 63

Other funds holding LABU

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

L.J. Altfest & Co's LABU Position: Q3 2022 in Review

L.J. Altfest & Co sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2022, closing a stake of 10,207 shares — an estimated $1.38M sold.

L.J. Altfest & Co first reported a position in LABU in Q2 2022 and held it in 1 quarter. The position peaked at $1.38M in Q2 2022. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.

  • L.J. Altfest & Co reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
  • L.J. Altfest & Co sold 10,207 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $1.38M.
  • L.J. Altfest & Co first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and held it in 1 quarter.
  • L.J. Altfest & Co's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.38M in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.

Based on L.J. Altfest & Co's 13F filing for Q3 2022, filed 15 Nov 2022.